Skip to content
healthcare.dev

Topiramate

NDC 24979-210, Topiramate, capsule, from Upsher-Smith Laboratories, LLC.

Product NDC
24979-210
Status
Listed
Labeler
Upsher-Smith Laboratories, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217694
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24979-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE15 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
24979-210-042497902100460 CAPSULE in 1 BOTTLE, PLASTIC (24979-210-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e0d88f34-865c-441b-80e2-e814c9a7d670
  • NADAC price for package 24979021004

    GET /v1/drugs/nadac/24979021004

Use it

Look up 24979-210 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24979-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24979-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.